Figure 4. Effect of CD81 expression on Overall Survival in favorable-risk patients.

Curve shown in black illustrates overall survival of patients with CD81⁻ AML (less than 20%), CD81⁺ in red (greater than 20%) for A. NPM1 mutated patients and B. ELN-favorable risk group. Numbers at risk at each year of follow-up are given. P-values based on logrank test.